Behavioral alterations in rat offspring following maternal immune activation and ELR-CXC chemokine receptor antagonism during pregnancy: Implications for neurodevelopmental psychiatric disorders

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 57, Issue , 2015, Pages 155-165

  Ballendine, Stephanie A ^a   Greba, Quentin ^a   Dawicki, Wojciech ^a   Zhang, Xiaobei ^a   Gordon, John R ^a   Howland, John G ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Crossmodal memory; Interleukin 8; Polyi:C; Schizophrenia; Set shifting

Indexed keywords

CHEMOKINE RECEPTOR ANTAGONIST; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; G 31P; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; POLYINOSINIC POLYCYTIDYLIC ACID; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CHEMOKINE RECEPTOR CXCR; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CXCL8(3-73)K11R,G31P; INTERLEUKIN 8; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATION PERIOD; INFLAMMATION; MALE; MATERNAL DISEASE; MATERNAL IMMUNE ACTIVATION; MATERNAL SERUM; MENTAL DISEASE; NERVE CELL DIFFERENTIATION; NONHUMAN; OPERANT BEHAVIORAL TEST; PREGNANCY; PREPULSE INHIBITION; PROGENY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RAT; RECOGNITION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; ASSOCIATION; BLOOD; BREEDING; DRUG EFFECTS; IMMUNOLOGY; INSTRUMENTAL CONDITIONING; LONG EVANS RAT; MENTAL DISORDERS; PRENATAL EXPOSURE; PSYCHOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; CHEMOKINE CXCL1; CHEMOKINE CXCL2; CONDITIONING, OPERANT; CUES; FEMALE; INTERLEUKIN-8; MALE; MENTAL DISORDERS; PEPTIDE FRAGMENTS; POLY I-C; PREGNANCY; PREGNANCY, ANIMAL; PRENATAL EXPOSURE DELAYED EFFECTS; PREPULSE INHIBITION; RATS; RATS, LONG-EVANS; RECEPTORS, CXCR; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; RECOGNITION (PSYCHOLOGY); SCHIZOPHRENIA;

EID: 84918560994     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.11.002     Document Type: Article

References (76)

1. Aaltonen R., Heikkinen T., Hakala K., Laine K., Alanen A. Transfer of proinflammatory cytokines across term placenta. Obstet Gynecol 2005, 106:802-807.
2. Arias I., Sorlozano A., Villegas E., de Dios L.J., McKenney K., Cervilla J., et al. Infectious agents associated with schizophrenia: a meta-analysis. Schizophr Res 2012, 136:128-136.
3. Arrode-Bruses G., Bruses J.L. Maternal immune activation by poly I:C induces expression of cytokines IL-1beta and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain. J Neuroinflammation 2012, 9:83.
4. Ashdown H., Dumont Y., Ng M., Poole S., Boksa P., Luheshi G.N. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry 2006, 11:47-55.
5. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I.N., Van de Water J. Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol 2011, 232:196-199.
6. Barker G.R., Bird F., Alexander V., Warburton E.C. Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex. J Neurosci 2007, 27:2948-2957.
7. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 2001, 156:234-258.
8. Bronson S.L., Ahlbrand R., Horn P.S., Kern J.R., Richtand N.M. Individual differences in maternal response to immune challenge predict offspring behavior: contribution of environmental factors. Behav Brain Res 2011, 220:55-64.
9. Brown A.S., Hooton J., Schaefer C.A., Zhang H., Petkova E., Babulas V., et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 2004, 161:889-895.
10. Carpentier P.A., Dingman A.L., Palmer T.D. Placental TNF-α signaling in illness-induced complications of pregnancy. Am J Pathol 2011, 178:2802-2810.
11. Cazakoff B.N., Howland J.G. AMPA receptor endocytosis in rat perirhinal cortex underlies retrieval of object memory. Learn Mem 2011, 18:688-692.
12. Cho C., Miller R.J. Chemokine receptors and neural function. J Neurovirol 2002, 8:573-584.
13. Deverman B.E., Patterson P.H. Cytokines and CNS development. Neuron 2009, 64:61-78.
14. Dickerson D.D., Wolff A.R., Bilkey D.K. Abnormal long-range neural synchrony in a maternal immune activation animal model of schizophrenia. J Neurosci 2010, 30:12424-12431.
15. Donegan J.J., Girotti M., Weinberg M.S., Morilak D.A. A novel role for brain interleukin-6: facilitation of cognitive flexibility in rat orbitofrontal cortex. J Neurosci 2014, 34:953-962.
16. Ellman L.M., Deicken R.F., Vinogradov S., Kremen W.S., Poole J.H., Kern D.M., et al. Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. Schizophr Res 2010, 121:46-54.
17. Enomoto T., Tse M.T., Floresco S.B. Reducing prefrontal gamma-aminobutyric acid activity induces cognitive, behavioral, and dopaminergic abnormalities that resemble schizophrenia. Biol Psychiatry 2011, 69:432-441.
18. Fineberg A.M., Ellman L.M. Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. Biol Psychiatry 2013, 73:951-966.
19. Floresco S.B., Block A.E., Tse M.T. Inactivation of the medial prefrontal cortex of the rat impairs strategy set-shifting, but not reversal learning, using a novel, automated procedure. Behav Brain Res 2008, 190:85-96.
20. Floresco S.B., Zhang Y., Enomoto T. Neural circuits subserving behavioral flexibility and their relevance to schizophrenia. Behav Brain Res 2009, 204:396-409.
21. Fortier M.E., Kent S., Ashdown H., Poole S., Boksa P., Luheshi G.N. The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. Am. J. Physiol Regul. Integr. Am J Physiol Regul Integr Comp Physiol 2004, 287:R759-R766.
22. Fortier M.E., Luheshi G.N., Boksa P. Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy. Behav Brain Res 2007, 181:270-277.
23. Garay P.A., Hsiao E.Y., Patterson P.H., McAllister A.K. Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development. Brain Behav Immun 2013, 31:54-68.
24. Gilmore J.H., Fredrik J.L., Vadlamudi S., Lauder J.M. Prenatal infection and risk for schizophrenia: IL-1beta, IL-6, and TNFalpha inhibit cortical neuron dendrite development. Neuropsychopharmacology 2004, 29:1221-1229.
25. Gilmore J.H., Jarskog L.F., Vadlamudi S. Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat. J Neuroimmunol 2005, 159:106-112.
26. Gordon J.R., Li F., Zhang X., Wang W., Zhao X., Nayyar A. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals. J Leukoc Biol 2005, 78:1265-1272.
27. Gordon J.R., Zhang X., Li F., Nayyar A., Zhao X. Amelioration of pathology by ELR-CXC chemokine antagonism in a swine model of airway endotoxin exposure. J Agromed 2009, 14:235-241.
28. Han X., Li N., Meng Q., Shao F., Wang W. Maternal immune activation impairs reversal learning and increases serum tumor necrosis factor-alpha in offspring. Neuropsychobiology 2011, 64:9-14.
29. Howland J.G., Hannesson D.K., Phillips A.G. Delayed onset of prepulse inhibition deficits following kainic acid treatment on postnatal day 7 in rats. Eur J Neurosci 2004, 20:2639-2648.
30. Howland J.G., Cazakoff B.N., Zhang Y. Altered object-in-place recognition memory, prepulse inhibition, and locomotor activity in the offspring of rats exposed to a viral mimetic during pregnancy. Neuroscience 2012, 201:184-198.
31. Hsiao E.Y., Patterson P.H. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun 2011, 25:604-615.
32. Jacklin D.L., Goel A., Clementino K.J., Hall A.W., Talpos J.C., Winters B.D. Severe cross-modal object recognition deficits in rats treated sub-chronically with NMDA receptor antagonists are reversed by systemic nicotine: implications for abnormal multisensory integration in schizophrenia. Neuropsychopharmacology 2012, 37:2322-2331.
33. Kamerman P., Skosana M., Loram L., Mitchell B., Weber J. Fever and inflammatory cytokine response in rats injected subcutaneously with viral double-stranded RNA analog, polyinosinic:polycytidylic acid (Poly-I:C). J Therm Biol 2011, 35:397-402.
34. Klein J., Hadar R., Gotz T., Manner A., Eberhardt C., Baldassarri J., et al. Mapping brain regions in which deep brain stimulation affects schizophrenia-like behavior in two rat models of schizophrenia. Brain Stimul 2013, 6:490-499.
35. Koenig J.I., Kirkpatrick B., Lee P. Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology 2002, 27:309-318.
36. Leeson V.C., Robbins T.W., Matheson E., Hutton S.B., Ron M.A., Barnes T.R., et al. Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry 2009, 66:586-593.
37. (3-73)K11R/G31P antagonizes the neutrophil chemoattractants present in pasteurellosis and mastitis lesions and abrogates neutrophil influx into intradermal endotoxin challenge sites in vivo. Vet Immunol Immunopathol 2002, 90:65-77.
38. Li Q., Cheung C., Wei R., Hui E.S., Feldon J., Meyer U., et al. Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model. PLoS One 2009, 4:e6354.
39. Marder S.R., Fenton W. Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr Res 2004, 72:5-9.
40. Mattei D., Djodari-Irani A., Hadar R., Pelz A., de Cossio L.F., Goetz T., et al. Minocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophrenia. Brain Behav Immun 2014, 38:175-184.
41. Meyer U., Feldon J. To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology 2012, 62:1308-1321.
42. Meyer U., Feldon J., Schedlowski M., Yee B.K. Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun 2006, 20:378-388.
43. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 2006, 26:4752-4762.
44. Meyer U., Feldon J., Fatemi S.H. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev 2009, 33:1061-1079.
45. Meyer U., Spoerri E., Yee B.K., Schwarz M.J., Feldon J. Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia. Schizophr Bull 2010, 36:607-623.
46. Meyer U., Weiner I., McAlonan G.M., Feldon J. The neuropathological contribution of prenatal inflammation to schizophrenia. Expert Rev Neurother 2011, 11:29-32.
47. Pantelis C., Barber F.Z., Barnes T.R., Nelson H.E., Owen A.M., Robbins T.W. Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr Res 1999, 37:251-270.
48. Patterson P.H. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 2009, 204:313-321.
49. Patterson P.H. Maternal infection and immune involvement in autism. Trends Mol Med 2011, 17:389-394.
50. Piontkewitz Y., Arad M., Weiner I. Tracing the development of psychosis and its prevention: what can be learned from animal models. Neuropharmacology 2012, 62:1273-1289.
51. Ragozzino D. CXC chemokine receptors in the central nervous system: role in cerebellar neuromodulation and development. J Neurovirol 2002, 8:559-572.
52. Reale M., Patruno A., De Lutiis M.A., Pesce M., Felaco M., Di G.M., et al. Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls. BMC Neurosci 2011, 12:13.
53. Reisenberger K., Egarter C., Vogl S., Sternberger B., Kiss H., Husslein P. The transfer of interleukin-8 across the human placenta perfused in vitro. Obstet Gynecol 1996, 87:613-616.
54. Sangha S., Greba Q., Robinson P.D., Ballendine S.A., Howland J.G. Heightened fear in response to a safety cue and extinguished fear cue in a rat model of maternal immune activation. Front Behav Neurosci 2014, 8:168.
55. Savanthrapadian S., Wolff A.R., Logan B.J., Eckert M.J., Bilkey D.K., Abraham W.C. Enhanced hippocampal neuronal excitability and LTP persistence associated with reduced behavioral flexibility in the maternal immune activation model of schizophrenia. Hippocampus 2013, 23:1395-1409.
56. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003, 23:297-302.
57. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007, 27:10695-10702.
58. Song Z., Wenqiang L., Yongfeng Y., Zhao J., Jiang C., Li W., et al. The nuclear factor-κB inhibitor pyrrolidine dithiocarbamate reduces polyinosinic-polycytidilic acid-induced immune response in pregnant rats and the behavioral defects of their adult offspring. Behav Brain Funct 2011, 7:1-9.
59. Stekelenburg J.J., Maes J.P., Van Gool A.R., Sitskoorn M., Vroomen J. Deficient multisensory integration in schizophrenia: an event-related potential study. Schizophr Res 2013, 147:253-261.
60. Stone D.B., Urrea L.J., Aine C.J., Bustillo J.R., Clark V.P., Stephen J.M. Unisensory processing and multisensory integration in schizophrenia: a high-density electrical mapping study. Neuropsychologia 2011, 49:3178-3187.
61. Stuart M.J., Baune B.T. Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies. Neurosci Biobeha Rev 2014, 42:93-115.
62. Thai C.A., Zhang Y., Howland J.G. Effects of acute restraint stress on set-shifting and reversal learning in male rats. Cogn Affect Behav Neurosci 2013, 13:164-173.
63. Tran P.B., Miller R.J. Chemokine receptors: signposts to brain development and disease. Nat Rev Neurosci 2003, 4:444-455.
64. Waltz J.A., Gold J.M. Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophr Res 2007, 93:296-303.
65. Watanabe Y., Someya T., Nawa H. Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. Psychiatry Clin Neurosci 2010, 64:217-230.
66. Wei J., Peng J., Wang B., Qu H., Wang S., Faisal A., et al. CXCR1/CXCR2 antagonism is effective in pulmonary defense against Klebsiella pneumoniae infection. Biomed Res Int 2013, 2013:720975.
67. Williams L.E., Light G.A., Braff D.L., Ramachandran V.S. Reduced multisensory integration in patients with schizophrenia on a target detection task. Neuropsychologia 2010, 48:3128-3136.
68. Winters B.D., Reid J.M. A distributed cortical representation underlies crossmodal object recognition in rats. J Neurosci 2010, 30:6253-6261.
69. Wolff A.R., Bilkey D.K. Immune activation during mid-gestation disrupts sensorimotor gating in rat offspring. Behav Brain Res 2008, 190:156-159.
70. Wolff A.R., Bilkey D.K. The maternal immune activation (MIA) model of schizophrenia produces pre-pulse inhibition (PPI) deficits in both juvenile and adult rats but these effects are not associated with maternal weight loss. Behav Brain Res 2010, 213:323-327.
71. Wood S.J., Proffitt T., Mahony K., Smith D.J., Buchanan J.A., Brewer W., et al. Visuospatial memory and learning in first-episode schizophreniform psychosis and established schizophrenia: a functional correlate of hippocampal pathology?. Psychol Med 2002, 32:429-438.
72. Young J.W., Powell S.B., Risbrough V., Marston H.M., Geyer M.A. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther 2009, 122:150-202.
73. Zhang Y., Cazakoff B.N., Thai C.A., Howland J.G. Prenatal exposure to a viral mimetic alters behavioural flexibility in male, but not female, rats. Neuropharmacology 2012, 62:1299-1307.
74. Zhao X., Town J.R., Li F., Zhang X., Cockcroft D.W., Gordon J.R. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels. J Immunol 2009, 182:3213-3222.
75. Zhao X., Town J.R., Yang A., Zhang X., Paur N., Sawicki G., et al. A novel ELR-CXC chemokine antagonist reduces intestinal ischemia reperfusion-induced mortality, and local and remote organ injury. J Surg Res 2010, 162:264-273.
76. Zuckerman L., Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 2005, 39:311-323.